Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (681-690 of 1,095) with videos related to

Pageof 110
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitorsL Schirosi, N Nannini, D Nicoli, et al.
BMJ Open|November 24, 2024
OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in CataloniaAdriana Palom, Ariadna Rando-Segura, Gema Fernandez, et al.
Frontiers in Public Health|August 4, 2023
Chronic conditions and multimorbidity among West African migrants in greater Barcelona, SpainMarina J MacKinnon, Camila A Picchio, Daniel K Nomah, et al.
Immunotherapy|February 1, 2019
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinomaMelissa Bersanelli, Letizia Gnetti, Elena Varotti, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLCPaola Bordi, Marzia Del Re, Roberta Minari, et al.
World Journal of Gastroenterology|April 16, 2019
Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfectionCristina Godoy, David Tabernero, Sara Sopena, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2024
Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three CasesStefano Volpi, Maria L Angelotti, Giulia Palazzini, et al.
Journal of Hepatology|April 7, 2024
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2Kosh Agarwal, Maria Buti, Florian van Bömmel, et al.
Immunotherapy|November 17, 2021
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Pageof 110

Showing results (681-690 of 1,095) with videos related to

Sort By:
Pageof 110
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitorsL Schirosi, N Nannini, D Nicoli, et al.
BMJ Open|November 24, 2024
OPTI-HEP-D: a protocol for an intervention study comprising screening and linkage to care of people living with hepatitis D in CataloniaAdriana Palom, Ariadna Rando-Segura, Gema Fernandez, et al.
Frontiers in Public Health|August 4, 2023
Chronic conditions and multimorbidity among West African migrants in greater Barcelona, SpainMarina J MacKinnon, Camila A Picchio, Daniel K Nomah, et al.
Immunotherapy|February 1, 2019
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinomaMelissa Bersanelli, Letizia Gnetti, Elena Varotti, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLCPaola Bordi, Marzia Del Re, Roberta Minari, et al.
World Journal of Gastroenterology|April 16, 2019
Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfectionCristina Godoy, David Tabernero, Sara Sopena, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2024
Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three CasesStefano Volpi, Maria L Angelotti, Giulia Palazzini, et al.
Journal of Hepatology|April 7, 2024
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2Kosh Agarwal, Maria Buti, Florian van Bömmel, et al.
Immunotherapy|November 17, 2021
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Pageof 110